RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Return 18.15%
This Quarter Return
-14.25%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
+$149M
Cap. Flow %
2.62%
Top 10 Hldgs %
45.45%
Holding
105
New
10
Increased
9
Reduced
7
Closed
8

Top Buys

1
BLU
BELLUS Health Inc.
BLU
$82.4M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$55.9M
3
LIAN
LianBio American Depositary Shares
LIAN
$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$34.8M

Top Sells

1
AVIR icon
Atea Pharmaceuticals
AVIR
$190M
2
TGTX icon
TG Therapeutics
TGTX
$35.9M
3
VERV
Verve Therapeutics
VERV
$21M
4
CTMX icon
CytomX Therapeutics
CTMX
$17.8M
5
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KNTE
26
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$63.7M 1.12%
3,593,052
– –
PHAT icon
27
Phathom Pharmaceuticals
PHAT
$851M
$61.3M 1.08%
3,115,008
– –
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$55.9M 0.99%
+381,046
New +$55.9M
ZGNX
29
DELISTED
Zogenix, Inc.
ZGNX
$54.2M 0.96%
3,333,700
– –
PRDS
30
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$51.2M 0.9%
3,127,038
+2,127,038
+213% +$34.8M
HOWL icon
31
Werewolf Therapeutics
HOWL
$61.7M
$51.1M 0.9%
4,291,881
– –
PNT
32
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$50.4M 0.89%
9,003,018
+147,000
+2% +$823K
RYTM icon
33
Rhythm Pharmaceuticals
RYTM
$6.95B
$48.6M 0.86%
4,871,067
– –
LIAN
34
DELISTED
LianBio American Depositary Shares
LIAN
$47.2M 0.83%
+7,655,015
New +$47.2M
DSGN icon
35
Design Therapeutics
DSGN
$348M
$46.8M 0.83%
2,186,636
– –
RCKT icon
36
Rocket Pharmaceuticals
RCKT
$349M
$46M 0.81%
2,107,149
– –
RLMD icon
37
Relmada Therapeutics
RLMD
$45.5M
$45.1M 0.79%
+2,000,000
New +$45.1M
CCCC icon
38
C4 Therapeutics
CCCC
$190M
$44.4M 0.78%
1,377,569
– –
TGTX icon
39
TG Therapeutics
TGTX
$5.06B
$42M 0.74%
2,210,145
-1,888,187
-46% -$35.9M
EYPT icon
40
EyePoint Pharmaceuticals
EYPT
$819M
$41.3M 0.73%
3,370,506
+1,160,000
+52% +$14.2M
CNTA
41
Centessa Pharmaceuticals
CNTA
$2.12B
$40.3M 0.71%
3,577,094
– –
EWTX icon
42
Edgewise Therapeutics
EWTX
$1.54B
$39.9M 0.7%
2,613,623
– –
PMVP icon
43
PMV Pharmaceuticals
PMVP
$76.3M
$39.5M 0.7%
1,710,265
– –
CYT
44
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$38.1M 0.67%
3,350,506
– –
GERN icon
45
Geron
GERN
$880M
$36.8M 0.65%
30,126,299
– –
IVVD icon
46
Invivyd
IVVD
$209M
$36.3M 0.64%
4,995,807
-344,323
-6% -$2.5M
CNTB
47
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$99.2M
$36M 0.63%
6,991,003
– –
RXST icon
48
RxSight
RXST
$347M
$34.3M 0.61%
3,052,796
– –
VRNA
49
Verona Pharma
VRNA
$9.19B
$34.3M 0.6%
5,100,000
– –
LENZ
50
LENZ Therapeutics
LENZ
$1.14B
$33.5M 0.59%
385,481
– –
1
2
3 4 5